01:25 PM EST, 02/06/2025 (MT Newswires) -- BioXcel Therapeutics ( BTAI ) said Thursday it will implement a 1-for-16 reverse stock split of its shares to help regain compliance with the minimum bid price listing rule on the Nasdaq.

The company said the shares will start trading on a split-adjusted basis on Feb. 10.

Shares of BioXcel were down about 35% in recent trading.

Price: 0.20, Change: -0.10, Percent Change: -34.76